CLMT Form 4: Director 7,403 RSUs Vested; 2,962 Shares Sold
Rhea-AI Filing Summary
Stephen P. Mawer, a director of Calumet, Inc. (CLMT), reported transactions dated 06/24/2025 on Form 4. He was credited with 7,403 Restricted Stock Units (reported as an acquisition) that are 100% vested and each equals one share or the cash value of one share. He separately reported a sale of 2,962 common shares on the same date. The filings show beneficial ownership rising to 291,055 shares after the RSU acquisition and ending at 288,093 shares following the sale. The reporting person elected to receive 40% of vested RSUs in the cash equivalent of common shares.
Positive
- 7,403 Restricted Stock Units are 100% vested, showing full entitlement
- Reported beneficial ownership remains high at 288,093 common shares after transactions
Negative
- Sale of 2,962 shares reduced direct holdings from 291,055 to 288,093
Insights
Director executed mixed equity actions increasing vested RSUs while selling a small block of shares.
What it means: The report shows 7,403 vested Restricted Stock Units were recorded as acquired and 2,962 shares were sold on 06/24/2025. The director's reported beneficial ownership remains substantial at 288,093 shares.
Why it matters: Insider activity from a director is relevant to governance transparency and signals how executives choose to realize compensation; the RSUs are fully vested and may have been settled partly in cash per the filing.
Vested RSUs were converted to an ownership entry and partially elected for cash settlement.
What it means: The filing clarifies that each Restricted Stock Unit equals one common share and that the reporting person elected to receive 40% of vested RSUs in cash equivalents. The RSUs reported are 100% vested.
Why it matters: This shows the mechanics of executive pay realization—vested equity being monetized and/or retained—affecting dilution and insider holding metrics reported to investors.